Ram Lal Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.20 M
as on 05-12-2024
- Paid Up Capital ₹ 3.49 M
as on 05-12-2024
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.50 Cr
as on 05-12-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth -0.59%
(FY 2022)
- Total Assets -0.44%
(FY 2022)
About Ram Lal Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.20 M and a paid-up capital of Rs 3.49 M.
The company has closed loans amounting to ₹1.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Santosh Bhattacharya and Mandira Bhattacharjee serve as directors at the Company.
- CIN/LLPIN
U85195WB1997PTC082492
- Company No.
082492
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ram Lal Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Bhattacharya  | Director | 02-Jan-1997 | Current |
| Mandira Bhattacharjee | Director | 02-Jan-1997 | Current |
Financial Performance of Ram Lal Laboratories.
Ram Lal Laboratories Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ram Lal Laboratories?
In 2020, Ram Lal Laboratories had a promoter holding of 97.85% and a public holding of 2.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aurio Pharma Laboratories Private LimitedActive 26 years 8 monthsSantosh Bhattacharya and Mandira Bhattacharjee are mutual person
Kingfisher East Bengal Football Team Private LimitedActive 26 years 9 monthsSantosh Bhattacharya is a mutual person
- Classic Designer & Developer Pvt.Ltd.Active 29 years 2 months
Mandira Bhattacharjee is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 02 Dec 1999 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Ram Lal Laboratories?
Ram Lal Laboratories has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ram Lal Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ram Lal Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
